| Date | Form | Description | Docs | XBRL | Pages |
| 08/04/08 | DEF 14A | Definitive proxy statements |
|
20 | |
| 06/09/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 03/13/08 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/12/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
76 | |
| 03/12/08 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 03/05/08 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 02/20/08 | UPLOAD | SEC-generated letter |
|
3 | |
| 01/15/08 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
57 | |
| 01/15/08 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 12/27/07 | 8-K | Current report filing |
|
13 |
Latest News & Events
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences to Host an Investor Webcast on June 26, 2025
Read More...Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage
Read More...